BioCentury
ARTICLE | Clinical News

Varisolve endovenous microfoam for sclerotherapy regulatory update

February 16, 2004 8:00 AM UTC

BGC said its Provensis Ltd subsidiary plans to respond by November to an FDA clinical hold on the company's Varisolve endovenous microfoam for varicose veins. FDA placed the compound on hold last yea...